Galmed Pharmaceuticals (GLMD) Beginning Cash Balance (2020 - 2025)
Galmed Pharmaceuticals (GLMD) recorded quarterly Beginning Cash Balance of $4.8 million in Q1 2025, up 60.28% quarter-over-quarter from $3.0 million in Q1 2024, and up 60.28% on a YoY basis from $3.0 million in Q1 2024.
Galmed Pharmaceuticals (GLMD) Beginning Cash Balance (2020 - 2025) Analysis & Trends
Galmed Pharmaceuticals' Beginning Cash Balance history runs 6 years deep, the most recent figure standing at $4.8 million for Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4.77 Mn |
| Mar 31, 2025 | 4.77 Mn |
| Mar 31, 2024 | 2.98 Mn |
| Mar 31, 2024 | 2.98 Mn |
| Mar 31, 2023 | 2.13 Mn |
| Mar 31, 2023 | 2.13 Mn |
| Mar 31, 2022 | 3.00 Mn |
| Mar 31, 2022 | 3.00 Mn |
| Mar 31, 2021 | 7.06 Mn |
| Mar 31, 2021 | 7.06 Mn |
| Mar 31, 2020 | 16.04 Mn |
| Mar 31, 2020 | 16.04 Mn |